Ishak Gabra Nader B, Mahmoud Omar, Ishikawa Oki, Shah Varun, Altshul Erica, Oron Maly, Mina Bushra
Department of Pulmonary and Critical Care Medicine, Lenox Hill Hospital, New York, New York.
Int J Angiol. 2019 Jun;28(2):80-92. doi: 10.1055/s-0039-1692452. Epub 2019 Jun 28.
Pulmonary hypertension is an uncommon disease that carries a significant morbidity and mortality. Pulmonary arterial hypertension is a subtype of pulmonary hypertension that describes a group of disease entities that lead to an elevation in precapillary pulmonary artery pressure. Despite advances in the diagnosis and treatment of pulmonary arterial hypertension, it remains a difficult disease to recognize and manage. In this review article, we will discuss the definition and diagnosis of pulmonary arterial hypertension. Additionally, we will discuss the ever-expanding management options, their mechanisms and strategies, including combination therapy and the most recent advances and future directions.
肺动脉高压是一种罕见疾病,具有较高的发病率和死亡率。动脉性肺动脉高压是肺动脉高压的一种亚型,描述了一组导致肺毛细血管前动脉压力升高的疾病实体。尽管在动脉性肺动脉高压的诊断和治疗方面取得了进展,但它仍然是一种难以识别和管理的疾病。在这篇综述文章中,我们将讨论动脉性肺动脉高压的定义和诊断。此外,我们还将讨论不断扩展的管理选择、其机制和策略,包括联合治疗以及最新进展和未来方向。